Anti-Cancer Drug, ABT-737 Combined With Chemotherapy Improves Tumor Response In Triple Negative Breast Cancers

"A combination of a new anti-cancer drug with conventional chemotherapy offers improved results for aggressive ‘triple negative’ breast cancers."

http://www.lifescientist.com.au/article/394129/combined_therapy_offers_promise_aggressive_breast_cancers/?eid=-2&uid=21776&utm_source=biotechnology-news-today&utm_medium=newsletter

(Click to link)